The DOI matches its Crossref record; 258 of the 258 references it cites were found in a registry or an index.
Epigenetics and Colorectal Cancer Pathogenesis
Open accessAbstract
Colorectal cancer (CRC) develops through a multistage process that results from the progressive accumulation of genetic mutations, and frequently as a result of mutations in the Wnt signaling pathway. However, it has become evident over the past two decades that epigenetic alterations of the chromatin, particularly the chromatin components in the promoter regions of tumor suppressors and oncogenes, play key roles in CRC pathogenesis. Epigenetic regulation is organized at multiple levels, involving primarily DNA methylation and selective histone modifications in cancer cells. Assessment of the CRC epigenome has revealed that virtually all CRCs have aberrantly methylated genes and that the average CRC methylome has thousands of abnormally methylated genes. Although relatively less is known about the patterns of specific histone modifications in CRC, selective histone modifications and resultant chromatin conformation have been shown to act, in concert with DNA methylation, to regulate gene expression to mediate CRC pathogenesis. Moreover, it is now clear that not only DNA methylation but also histone modifications are reversible processes. The increased understanding of epigenetic regulation of gene expression in the context of CRC pathogenesis has led to development of epigenetic biomarkers for CRC diagnosis and epigenetic drugs for CRC therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Datta, J., Ghoshal, K., Denny, W. A., Gamage, S. A., Brooke, D. G., Phiasivongsa, P., Redkar, S., & Jacob, S. T. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3669 · Cited by 270
RetractedPancione, M., Sabatino, L., Fucci, A., Carafa, V., Nebbioso, A., Forte, N. R., Febbraro, A., Parente, D., Ambrosino, C., Normanno, N., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014229 · Cited by 72
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
High-Resolution Profiling of Histone Methylations in the Human Genome
Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., & Zhao, K. (2007) · Cell · doi:10.1016/j.cell.2007.05.009 · Cited by 6,845 · cited 4×
“In addition, although development and therapeutic use of HMTase and HDM inhibitors are still in its infancy, selective inhibitors of specific HMTases and HDMs are promising next generation ―epi-drugs‖ that are waiting to be discovered and developed in the years to come.”
BackgroundInfluentialGenetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Regulation of chromatin by histone modifications
Bannister, A. J., & Kouzarides, T. (2011) · Cell Research · doi:10.1038/cr.2011.22 · Cited by 6,012 · cited 2×
“Like histone acetylation, histone methylation is also now appreciated as a reversible process [152,155,156].”
BackgroundA bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332 · cited 4×
“Although it was developed more than 50 years ago, 5-FU is still the backbone of treatment for patients with colorectal cancer, especially metastatic colorectal cancer [205,240].”
BackgroundInfluentialJemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
Mikkelsen, T. S., Ku, M., Jaffe, D. B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Brockman, W., Kim, T.-K., Koche, R. P., et al. (2007) · Nature · doi:10.1038/nature06008 · Cited by 4,129
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
Li, E., Bestor, T. H., & Jaenisch, R. (1992) · Cell · doi:10.1016/0092-8674(92)90611-f · Cited by 3,984 · cited 1×
“DNA methylation is essential for mammalian development [79] and serves an important function in X-chromosome inactivation [80] and genomic imprinting [81].”
BackgroundThe Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169
The Genomic Landscapes of Human Breast and Colorectal Cancers
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., et al. (2007) · Science · doi:10.1126/science.1145720 · Cited by 2,833
Sharma, S., Kelly, T. K., & Jones, P. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp220 · Cited by 2,637
CpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J.-P. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,523
Microsatellite Instability in Colorectal Cancer
Boland, C. R., & Goel, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.064 · Cited by 2,456
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Histone methylation: a dynamic mark in health, disease and inheritance
Greer, E. L., & Shi, Y. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3173 · Cited by 2,241 · cited 1×
“a family history of CRC was associated with a high risk of CRC with low level of LINE-1 methylation [151].”
BackgroundThe Polycomb group protein EZH2 directly controls DNA methylation
Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., et al. (2006) · Nature · doi:10.1038/nature04431 · Cited by 2,204
Irizarry, R. A., Ladd-Acosta, C., Wen, B., Wu, Z., Montano, C., Onyango, P., Cui, H., Gabo, K., Rongione, M., Webster, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.298 · Cited by 2,177
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051424 · Cited by 2,135 · cited 1×
“survival On the other hand, CIMP high and MSI tumors are frequently infiltrated by a large number of T cells and are associated with longer patient survival [66–71], suggesting the a association between tumorinfiltrating immune cells, tumor cell methylation phenotypes and CRC patient clinical outcomes [52,55],”
BackgroundNatural Innate and Adaptive Immunity to Cancer
Vesely, M. D., Kershaw, M. H., Schreiber, R. D., & Smyth, M. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101324 · Cited by 2,101
Molecular Basis of Colorectal Cancer
Markowitz, S. D., & Bertagnolli, M. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804588 · Cited by 2,052
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
Genetic instability in colorectal cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386623a0 · Cited by 1,986
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974 · cited 1×
“It is estimated that chronic inflammation, likely to be caused by a dysregulated intestinal microbiota, contributes to approximately 20% of all CRC cases [4,7].”
BackgroundRole for DNA methylation in genomic imprinting
Li, E., Beard, C., & Jaenisch, R. (1993) · Nature · doi:10.1038/366362a0 · Cited by 1,964
Molecular Genetics of Colorectal Cancer
Fearon, E. R. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130235 · Cited by 1,805
Acetylation of Histones and Transcription-Related Factors
Sterner, D. E., & Berger, S. L. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.2.435-459.2000 · Cited by 1,780
Role for DNA methylation in genomic imprinting
Li, E., Beard, C., & Jaenisch, R. (1994) · Trends in Genetics · doi:10.1016/0168-9525(94)90228-3 · Cited by 1,691
Adoptive immunotherapy for cancer: harnessing the T cell response
Restifo, N. P., Dudley, M. E., & Rosenberg, S. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3191 · Cited by 1,688 · cited 1×
“tumor-specific CTL use to eliminate tumor [233–235].”
Kopetz, S., Chang, G. J., Overman, M. J., Eng, C., Sargent, D. J., Larson, D. W., Grothey, A., Vauthey, J.-N., Nagorney, D. M., & McWilliams, R. R. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.5278 · Cited by 1,339
Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J. C., & Perucho, M. (1997) · Science · doi:10.1126/science.275.5302.967 · Cited by 1,326
Le Voyer, T. E., Sigurdson, E. R., Hanlon, A. L., Mayer, R. J., Macdonald, J. S., Catalano, P. J., & Haller, D. G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.062 · Cited by 1,149
Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark
Ruthenburg, A. J., Allis, C. D., & Wysocka, J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.12.014 · Cited by 1,147
Ohm, J. E., McGarvey, K. M., Yu, X., Cheng, L., Schuebel, K. E., Cope, L., Mohammad, H. P., Chen, W., Daniel, V. C., Yu, W., et al. (2007) · Nature Genetics · doi:10.1038/ng1972 · Cited by 1,130
Lymph Node Evaluation and Survival After Curative Resection of Colon Cancer: Systematic Review
Chang, G. J., Rodriguez-Bigas, M. A., Skibber, J. M., & Moyer, V. A. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk092 · Cited by 1,039
Salama, P., Phillips, M., Grieu, F., Morris, M., Zeps, N., Joseph, D., Platell, C., & Iacopetta, B. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.7229 · Cited by 991
DNA hypomethylation leads to elevated mutation rates
Chen, R. Z., Pettersson, U., Beard, C., Jackson-Grusby, L., & Jaenisch, R. (1998) · Nature · doi:10.1038/25779 · Cited by 954
DePinho, R. A. (2000) · Nature · doi:10.1038/35041694 · Cited by 951
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
Daigle, S. R., Olhava, E. J., Therkelsen, C. A., Majer, C. R., Sneeringer, C. J., Song, J., Johnston, L. D., Scott, M. P., Smith, J. J., Xiao, Y., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.009 · Cited by 923
Regulation of histone methylation by demethylimination and demethylation
Klose, R. J., & Zhang, Y. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2143 · Cited by 887
Bandrés, E., Cubedo, E., Agirre, X., Malumbres, R., Zárate, R., Ramírez, N., Abajo, A., Navarro, A., Moreno, I., Monzó, M., et al. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-29 · Cited by 884
Smyth, M. J., Dunn, G. P., & Schreiber, R. D. (2006) · Advances in Immunology · doi:10.1016/s0065-2776(06)90001-7 · Cited by 870
Reversal of H3K9me2 by a Small-Molecule Inhibitor for the G9a Histone Methyltransferase
Kubicek, S., O'Sullivan, R. J., August, E. M., Hickey, E. R., Zhang, Q., Teodoro, M. L., Rea, S., Mechtler, K., Kowalski, J. A., Homon, C. A., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.01.017 · Cited by 859
Roles of the EZH2 histone methyltransferase in cancer epigenetics
Simon, J. A., & Lange, C. A. (2008) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2008.07.010 · Cited by 855
Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L.-C., Bapat, B., Gallinger, S., Andrulis, I. L., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80128-2 · Cited by 845
Ligtenberg, M. J. L., Kuiper, R. P., Chan, T. L., Goossens, M., Hebeda, K. M., Voorendt, M., Lee, T. Y. H., Bodmer, D., Hoenselaar, E., Hendriks-Cornelissen, S. J. B., et al. (2009) · Nature Genetics · doi:10.1038/ng.283 · Cited by 818
DNA Methylation: Superior or Subordinate in the Epigenetic Hierarchy?
Jin, B., Li, Y., & Robertson, K. D. (2011) · Genes & Cancer · doi:10.1177/1947601910393957 · Cited by 817
Cancer classification using the Immunoscore: a worldwide task force
Galon, J., Pagès, F., Marincola, F. M., Angell, H. K., Thurin, M., Lugli, A., Zlobec, I., Berger, A., Bifulco, C., Botti, G., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-205 · Cited by 791
Ogino, S., Nosho, K., Kirkner, G. J., Kawasaki, T., Meyerhardt, J. A., Loda, M., Giovannucci, E. L., & Fuchs, C. S. (2009) · Gut · doi:10.1136/gut.2008.155473 · Cited by 777
Cummins, J. M., He, Y., Leary, R. J., Pagliarini, R., Diaz, L. A., Sjoblom, T., Barad, O., Bentwich, Z., Szafranska, A. E., Labourier, E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511155103 · Cited by 744
Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours
Esteller, M., & Herman, J. G. (2002) · The Journal of Pathology · doi:10.1002/path.1024 · Cited by 743
Epigenetics and colorectal cancer
Lao, V. V., & Grady, W. M. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.173 · Cited by 736
Coca, S., Perez-Piqueras, J., Martinez, D., Colmenarejo, A., Saez, M. A., Vallejo, C., Martos, J. A., & Moreno, M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970615)79:12<2320::aid-cncr5>3.0.co;2-p · Cited by 716
Accelerated age-related CpG island methylation in ulcerative colitis.
Issa, J. J., Ahuja, N., Toyota, M., Bronner, M. P., & Brentnall, T. A. (2001) · PubMed · Cited by 690
Juergens, R. A., Wrangle, J., Vendetti, F. P., Murphy, S. C., Zhao, M., Coleman, B., Sebree, R., Rodgers, K., Hooker, C. M., Franco, N., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0214 · Cited by 686
The genetics of the p53 pathway, apoptosis and cancer therapy
Vazquez, A., Bond, E. E., Levine, A. J., & Bond, G. L. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2656 · Cited by 676
SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis
Vaquero, A., Scher, M. B., Lee, D. H., Sutton, A., Cheng, H.-L., Alt, F. W., Serrano, L., Sternglanz, R., & Reinberg, D. (2006) · Genes & Development · doi:10.1101/gad.1412706 · Cited by 665
Jones, P. A. (1999) · Trends in Genetics · doi:10.1016/s0168-9525(98)01636-9 · Cited by 665
Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate
Santi, D. V., McHenry, C. S., & Sommer, H. (1974) · Biochemistry · doi:10.1021/bi00700a012 · Cited by 619
Intestinal Tumorigenesis in Compound Mutant Mice of both Dpc4(Smad4) and Apc Genes
Takaku, K., Oshima, M., Miyoshi, H., Matsui, M., Seldin, M. F., & Taketo, M. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81132-0 · Cited by 609
Genome-scale analysis of aberrant DNA methylation in colorectal cancer
Hinoue, T., Weisenberger, D. J., Lange, C. P. E., Shen, H., Byun, H.-M., Van Den Berg, D., Malik, S., Pan, F., Noushmehr, H., van Dijk, C. M., et al. (2012) · Genome Research · doi:10.1101/gr.117523.110 · Cited by 601
The diverse functions of Dot1 and H3K79 methylation
Nguyen, A. T., & Zhang, Y. (2011) · Genes & Development · doi:10.1101/gad.2057811 · Cited by 597
Samowitz, W. S., Albertsen, H., Herrick, J., Levin, T. R., Sweeney, C., Murtaugh, M. A., Wolff, R. K., & Slattery, M. L. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.020 · Cited by 577
Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer
Shen, L., Toyota, M., Kondo, Y., Lin, E., Zhang, L., Guo, Y., Hernandez, N. S., Chen, X., Ahmed, S., Konishi, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704652104 · Cited by 559
Adoptive T cell therapy for cancer in the clinic
June, C. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32446 · Cited by 553
The genetics of hereditary colon cancer
Rustgi, A. K. (2007) · Genes & Development · doi:10.1101/gad.1593107 · Cited by 529
A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells
Vedadi, M., Barsyte-Lovejoy, D., Liu, F., Rival-Gervier, S., Allali-Hassani, A., Labrie, V., Wigle, T. J., DiMaggio, P. A., Wasney, G. A., Siarheyeva, A., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.599 · Cited by 527
Polycomb group proteins: navigators of lineage pathways led astray in cancer
Bracken, A. P., & Helin, K. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2736 · Cited by 523
Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9
Greiner, D., Bonaldi, T., Eskeland, R., Roemer, E., & Imhof, A. (2005) · Nature Chemical Biology · doi:10.1038/nchembio721 · Cited by 521
Mechanisms for the Inhibition of DNA Methyltransferases by Tea Catechins and Bioflavonoids
Lee, W. J., Shim, J.-Y., & Zhu, B. T. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008367 · Cited by 507
Nosho, K., Baba, Y., Tanaka, N., Shima, K., Hayashi, M., Meyerhardt, J. A., Giovannucci, E., Dranoff, G., Fuchs, C. S., & Ogino, S. (2010) · The Journal of Pathology · doi:10.1002/path.2774 · Cited by 502
Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer
Schepeler, T., Reinert, J. T., Ostenfeld, M. S., Christensen, L. L., Silahtaroglu, A. N., Dyrskjøt, L., Wiuf, C., Sørensen, F. J., Kruhøffer, M., Laurberg, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6110 · Cited by 492
Chen, L.-W., Egan, L., Li, Z.-W., Greten, F. R., Kagnoff, M. F., & Karin, M. (2003) · Nature Medicine · doi:10.1038/nm849 · Cited by 483
Regulation of the Adenomatous Polyposis Coli Gene by the miR-135 Family in Colorectal Cancer
Nagel, R., le Sage, C., Diosdado, B., van der Waal, M., Oude Vrielink, J. A. F., Bolijn, A., Meijer, G. A., & Agami, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0951 · Cited by 474
Dietary Polyphenols May Affect DNA Methylation
Fang, M., Chen, D., & Yang, C. S. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.1.223s · Cited by 462
Yeast Rtt109 Promotes Genome Stability by Acetylating Histone H3 on Lysine 56
Driscoll, R., Hudson, A., & Jackson, S. P. (2007) · Science · doi:10.1126/science.1135862 · Cited by 439
Cheng, H., Zhang, L., Cogdell, D. E., Zheng, H., Schetter, A. J., Nykter, M., Harris, C. C., Chen, K., Hamilton, S. R., & Zhang, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017745 · Cited by 430
Rtt109 Acetylates Histone H3 Lysine 56 and Functions in DNA Replication
Han, J., Zhou, H., Horazdovsky, B., Zhang, K., Xu, R.-M., & Zhang, Z. (2007) · Science · doi:10.1126/science.1133234 · Cited by 421
Ogino, S., Nosho, K., Irahara, N., Meyerhardt, J. A., Baba, Y., Shima, K., Glickman, J. N., Ferrone, C. R., Mino-Kenudson, M., Tanaka, N., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1438 · Cited by 418
Profile of Histone Lysine Methylation across Transcribed Mammalian Chromatin
Vakoc, C. R., Sachdeva, M. M., Wang, H., & Blobel, G. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01529-06 · Cited by 406
Dependence of histone modifications and gene expression on DNA hypermethylation in cancer.
Fahrner, J. A., Eguchi, S., Herman, J. G., & Baylin, S. B. (2002) · PubMed · Cited by 399
DNA methylation and genetic instability in colorectal cancer cells
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2545 · Cited by 396
Acetylation in Histone H3 Globular Domain Regulates Gene Expression in Yeast
Xu, F., Zhang, K., & Grunstein, M. (2005) · Cell · doi:10.1016/j.cell.2005.03.011 · Cited by 394
A Cohort Study of Tumoral LINE-1 Hypomethylation and Prognosis in Colon Cancer
Ogino, S., Nosho, K., Kirkner, G. J., Kawasaki, T., Chan, A. T., Schernhammer, E. S., Giovannucci, E. L., & Fuchs, C. S. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn359 · Cited by 377
Epigenetics, DNA Methylation, and Chromatin Modifying Drugs
Szyf, M. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061008-103102 · Cited by 374
Lee, W. J., & Zhu, B. T. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi206 · Cited by 372 · cited 1×
“Furthermore, natural products, such as dietary catechol-containing polyphenols, are currently receiving much attention [218–221].”
BackgroundLymph Node Recoveries From 2427 pT3 Colorectal Resection Specimens Spanning 45 Years
Goldstein, N. S. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200202000-00004 · Cited by 371
Weichert, W., Röske, A., Niesporek, S., Noske, A., Buckendahl, A.-C., Dietel, M., Gekeler, V., Boehm, M., Beckers, T., & Denkert, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0990 · Cited by 361
MicroRNAs in colorectal cancer: translation of molecular biology into clinical application
Slaby, O., Svoboda, M., Michalek, J., & Vyzula, R. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-102 · Cited by 356
Over- and under-expressed microRNAs in human colorectal cancer
Mori (2009) · International Journal of Oncology · doi:10.3892/ijo_00000233 · Cited by 348
Colorectal cancer molecular biology moves into clinical practice
Pritchard, C. C., & Grady, W. M. (2011) · Gut · doi:10.1136/gut.2009.206250 · Cited by 344
Epigenomic Enhancer Profiling Defines a Signature of Colon Cancer
Akhtar-Zaidi, B., Cowper-Sal·lari, R., Corradin, O., Saiakhova, A., Bartels, C. F., Balasubramanian, D., Myeroff, L., Lutterbaugh, J., Jarrar, A., Kalady, M. F., et al. (2012) · Science · doi:10.1126/science.1217277 · Cited by 339
Epigenetic changes in colorectal cancer
Kondo, Y., & Issa, J.-P. J. (2004) · Cancer and Metastasis Reviews · doi:10.1023/a:1025806911782 · Cited by 338
Slattery, M. L. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.22.1831 · Cited by 335
Enhanced CpG Mutability and Tumorigenesis in MBD4-Deficient Mice
Millar, C. B., Guy, J., Sansom, O. J., Selfridge, J., MacDougall, E., Hendrich, B., Keightley, P. D., Bishop, S. M., Clarke, A. R., & Bird, A. (2002) · Science · doi:10.1126/science.1073354 · Cited by 328
Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability
Hermsen, M., Postma, C., Baak, J., Weiss, M., Rapallo, A., Sciutto, A., Roemen, G., Arends, J., Williams, R., Giaretti, W., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.36051 · Cited by 328
DNA Methylation: An Alternative Pathway to Cancer
Wajed, S. A., Laird, P. W., & DeMeester, T. R. (2001) · Annals of Surgery · doi:10.1097/00000658-200107000-00003 · Cited by 327
Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer
Chan, T. L., Yuen, S. T., Kong, C. K., Chan, Y. W., Chan, A. S., Ng, W. F., Tsui, W. Y., Lo, M. W., Tam, W. Y., Li, V. S., et al. (2006) · Nature Genetics · doi:10.1038/ng1866 · Cited by 324
Guidoboni, M., Gafà, R., Viel, A., Doglioni, C., Russo, A., Santini, A., Del Tin, L., Macrì, E., Lanza, G., Boiocchi, M., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61695-1 · Cited by 322 · cited 1×
“survival On the other hand, CIMP high and MSI tumors are frequently infiltrated by a large number of T cells and are associated with longer patient survival [66–71], suggesting the a association between tumorinfiltrating immune cells, tumor cell methylation phenotypes and CRC patient clinical outcomes [52,55],”
BackgroundIncreased Cytosine DNA-Methyltransferase Activity During Colon Cancer Progression
Issa, J.-P. J., Vertino, P. M., Wu, J., Sazawal, S., Celano, P., Nelkin, B. D., Hamilton, S. R., & Baylin, S. B. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.15.1235 · Cited by 312
Nosho, K., Irahara, N., Shima, K., Kure, S., Kirkner, G. J., Schernhammer, E. S., Hazra, A., Hunter, D. J., Quackenbush, J., Spiegelman, D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003698 · Cited by 311
Sarver, A. L., French, A. J., Borralho, P. M., Thayanithy, V., Oberg, A. L., Silverstein, K. A., Morlan, B. W., Riska, S. M., Boardman, L. A., Cunningham, J. M., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-401 · Cited by 310
Vogt, M., Munding, J., Grüner, M., Liffers, S.-T., Verdoodt, B., Hauk, J., Steinstraesser, L., Tannapfel, A., & Hermeking, H. (2011) · Virchows Archiv · doi:10.1007/s00428-010-1030-5 · Cited by 309
Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294
Chang, Y., Zhang, X., Horton, J. R., Upadhyay, A. K., Spannhoff, A., Liu, J., Snyder, J. P., Bedford, M. T., & Cheng, X. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1560 · Cited by 308
Möller, P., Koretz, K., Leithäuser, F., Brüderlein, S., Henne, C., Quentmeier, A., & Krammer, P. H. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570314 · Cited by 306
Microsatellite instability in colorectal cancer
Söreide, K., Janssen, E. A. M., Söiland, H., Körner, H., & Baak, J. P. A. (2006) · British Journal of Surgery · doi:10.1002/bjs.5328 · Cited by 302
Ogino, S., Kawasaki, T., Kirkner, G. J., Loda, M., & Fuchs, C. S. (2006) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.060082 · Cited by 294
Hypermethylator Phenotype in Sporadic Colon Cancer: Study on a Population-Based Series of 582 Cases
Barault, L., Charon-Barra, C., Jooste, V., de la Vega, M. F., Martin, L., Roignot, P., Rat, P., Bouvier, A.-M., Laurent-Puig, P., Faivre, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1171 · Cited by 286
Cancer immunology—analysis of host and tumor factors for personalized medicine
Ogino, S., Galon, J., Fuchs, C. S., & Dranoff, G. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.122 · Cited by 284
van Rijnsoever, M., Elsaleh, H., Joseph, D. J., McCaul, K. A., & Iacopetta, B. J. (2003) · UWA Profiles and Research Repository (UWA) · Cited by 282
Serrated Polyps and Colorectal Cancer: New Pathway to Malignancy
Noffsinger, A. E. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092317 · Cited by 282
Arnold, C. N., Goel, A., & Boland, C. R. (2003) · International Journal of Cancer · doi:10.1002/ijc.11176 · Cited by 280
Zimmerman, M. A., Singh, N., Martin, P. M., Thangaraju, M., Ganapathy, V., Waller, J. L., Shi, H., Robertson, K. D., Munn, D. H., & Liu, K. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00543.2011 · Cited by 276
Self-citationCarcinogenesis in IBD: potential targets for the prevention of colorectal cancer
Feagins, L. A., Souza, R. F., & Spechler, S. J. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.44 · Cited by 274
Estécio, M. R. H., Gharibyan, V., Shen, L., Ibrahim, A. E. K., Doshi, K., He, R., Jelinek, J., Yang, A. S., Yan, P. S., Huang, T. H.-M., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000399 · Cited by 270
Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage
Suzuki, K., Suzuki, I., Leodolter, A., Alonso, S., Horiuchi, S., Yamashita, K., & Perucho, M. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.016 · Cited by 269
Ogino, S., Shima, K., Meyerhardt, J. A., McCleary, N. J., Ng, K., Hollis, D., Saltz, L. B., Mayer, R. J., Schaefer, P., Whittom, R., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2246 · Cited by 267
Noordhuis, P., Holwerda, U., Van der Wilt, C. L., Van Groeningen, C. J., Smid, K., Meijer, S., Pinedo, H. M., & Peters, G. J. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh264 · Cited by 264
Ogino, S., Kawasaki, T., Nosho, K., Ohnishi, M., Suemoto, Y., Kirkner, G. J., & Fuchs, C. S. (2008) · International Journal of Cancer · doi:10.1002/ijc.23470 · Cited by 261
Arndt, G. M., Dossey, L., Cullen, L. M., Lai, A., Druker, R., Eisbacher, M., Zhang, C., Tran, N., Fan, H., Retzlaff, K., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-374 · Cited by 260
Yoshioka, A., Tanaka, S., Hiraoka, O., Koyama, Y., Hirota, Y., Ayusawa, D., Seno, T., Garrett, C., & Wataya, Y. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47554-0 · Cited by 252
Colorectal cancer: a tale of two sides or a continuum?: Figure 1
Yamauchi, M., Lochhead, P., Morikawa, T., Huttenhower, C., Chan, A. T., Giovannucci, E., Fuchs, C., & Ogino, S. (2012) · Gut · doi:10.1136/gutjnl-2012-302014 · Cited by 250
A High Degree of LINE-1 Hypomethylation Is a Unique Feature of Early-Onset Colorectal Cancer
Antelo, M., Balaguer, F., Shia, J., Shen, Y., Hur, K., Moreira, L., Cuatrecasas, M., Bujanda, L., Giraldez, M. D., Takahashi, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045357 · Cited by 249
Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis
Yamada, Y., Jackson-Grusby, L., Linhart, H., Meissner, A., Eden, A., Lin, H., & Jaenisch, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506612102 · Cited by 245
Cancer Cells Exhibit a Mutator Phenotype
(1997) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60699-5 · Cited by 242
SPARC in cancer biology: Its role in cancer progression and potential for therapy
Tai, I. T., & Tang, M. J. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2008.08.005 · Cited by 242
Fleisher, A. S., Esteller, M., Harpaz, N., Leytin, A., Rashid, A., Xu, Y., Liang, J., Stine, O. C., Yin, J., Zou, T., et al. (2000) · PubMed · Cited by 231
Dahlin, A. M., Henriksson, M. L., Van Guelpen, B., Stenling, R., Öberg, Å., Rutegård, J., & Palmqvist, R. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.234 · Cited by 228
Yu, J., Cao, Q., Mehra, R., Laxman, B., Yu, J., Tomlins, S. A., Creighton, C. J., Dhanasekaran, S. M., Shen, R., Chen, G., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.016 · Cited by 223
Clinicopathological Significance of microRNA-31, -143 and -145 Expression in Colorectal Cancer
Wang, C.-J., Zhou, Z.-G., Wang, L., Yang, L., Zhou, B., Gu, J., Chen, H.-Y., & Sun, X.-F. (2009) · Disease Markers · doi:10.1155/2009/921907 · Cited by 223
Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis
Menon, A. G., Janssen - van Rhijn, C. M., Morreau, H., Putter, H., Tollenaar, R. A. E. M., van de Velde, C. J. H., Fleuren, G. J., & Kuppen, P. J. K. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700055 · Cited by 217
The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability
Riccio, A., Aaltonen, L. A., Godwin, A. K., Loukola, A., Percesepe, A., Salovaara, R., Masciullo, V., Genuardi, M., Paravatou-Petsotas, M., Bassi, D. E., et al. (1999) · Nature Genetics · doi:10.1038/15443 · Cited by 209
Rtt109 Is Required for Proper H3K56 Acetylation
Schneider, J., Bajwa, P., Johnson, F. C., Bhaumik, S. R., & Shilatifard, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600265200 · Cited by 209
PcG Proteins, DNA Methylation, and Gene Repression by Chromatin Looping
Tiwari, V. K., McGarvey, K. M., Licchesi, J. D. F., Ohm, J. E., Herman, J. G., Schübeler, D., & Baylin, S. B. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060306 · Cited by 207
Jover, R., Nguyen, T., Pérez–Carbonell, L., Zapater, P., Payá, A., Alenda, C., Rojas, E., Cubiella, J., Balaguer, F., Morillas, J. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.12.035 · Cited by 205
Structural Basis of Substrate Methylation and Inhibition of SMYD2
Ferguson, A. D., Larsen, N. A., Howard, T., Pollard, H., Green, I., Grande, C., Cheung, T., Garcia-Arenas, R., Cowen, S., Wu, J., et al. (2011) · Structure · doi:10.1016/j.str.2011.06.011 · Cited by 203 · cited 2×
“Chaetocin, BIX-01294, UNC0638, BRD4770, EPZ004777, AZ505, and PDB4e47 are other relatively selective HMTase inhibitors identified by random chemical library screening [206–211].”
BackgroundChiba, T., Ohtani, H., Mizoi, T., Naito, Y., Sato, E., Nagura, H., Ohuchi, A., Ohuchi, K., Shiiba, K., Kurokawa, Y., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602201 · Cited by 201
DNA mismatch repair genes and colorectal cancer
WHEELER, J. M. D., BODMER, W. F., WHEELER, J. M. D., & MORTENSEN, N. J. M. (2000) · Gut · doi:10.1136/gut.47.1.148 · Cited by 201
Colorectal Cancer Epigenetics: Complex Simplicity
van Engeland, M., Derks, S., Smits, K. M., Meijer, G. A., & Herman, J. G. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.2319 · Cited by 199
Michael-Robinson, J. M., Biemer-Hüttmann, A.-E., Purdie, D. M., Walsh, M. D., Simms, L. A., Biden, K. G., Young, J. P., Leggett, B. A., Jass, J. R., & Radford-Smith, G. L. (2001) · Gut · doi:10.1136/gut.48.3.360 · Cited by 198
Gonzalez, M. E., Li, X., Toy, K., DuPrie, M., Ventura, A. C., Banerjee, M., Ljungman, M., Merajver, S. D., & Kleer, C. G. (2009) · Oncogene · doi:10.1038/onc.2008.433 · Cited by 195
Ougolkov, A. V., Bilim, V. N., & Billadeau, D. D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1013 · Cited by 193
Ward, R. L., Cheong, K., Ku, S.-L., Meagher, A., O’Connor, T., & Hawkins, N. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.123 · Cited by 193
Douglas, E. J., Fiegler, H., Rowan, A., Halford, S., Bicknell, D. C., Bodmer, W., Tomlinson, I. P. M., & Carter, N. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0328 · Cited by 192
Campbell, P. T., Jacobs, E. T., Ulrich, C. M., Figueiredo, J. C., Poynter, J. N., McLaughlin, J. R., Haile, R. W., Jacobs, E. J., Newcomb, P. A., Potter, J. D., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq011 · Cited by 187
IFNγ-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice
Hanada, T., Kobayashi, T., Chinen, T., Saeki, K., Takaki, H., Koga, K., Minoda, Y., Sanada, T., Yoshioka, T., Mimata, H., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060436 · Cited by 187
Methylation Subtypes and Large-Scale Epigenetic Alterations in Gastric Cancer
Zouridis, H., Deng, N., Ivanova, T., Zhu, Y., Wong, B., Huang, D., Wu, Y. H., Wu, Y., Tan, I. B., Liem, N., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004504 · Cited by 186
Overlapping expression of microRNAs in human embryonic colon and colorectal cancer
Monzo, M., Navarro, A., Bandres, E., Artells, R., Moreno, I., Gel, B., Ibeas, R., Moreno, J., Martinez, F., Diaz, T., et al. (2008) · Cell Research · doi:10.1038/cr.2008.81 · Cited by 184
Wang, T.-L., Diaz, L. A., Romans, K., Bardelli, A., Saha, S., Galizia, G., Choti, M., Donehower, R., Parmigiani, G., Shih, I.-M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308716101 · Cited by 183
Earle, J. S. L., Luthra, R., Romans, A., Abraham, R., Ensor, J., Yao, H., & Hamilton, S. R. (2010) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2010.090154 · Cited by 180
Apoptosis induced by overexpression of hMSH2 or hMLH1.
Zhang, H., Richards, B. T., Wilson, T., Lloyd, M., Cranston, A. N., Thorburn, A. M., Fishel, R. A., & Meuth, M. (1999) · PubMed · Cited by 176
Vansteenkiste, J., Van Cutsem, E., Dumez, H., Chen, C., Ricker, J. L., Randolph, S. S., & Schöffski, P. (2008) · Investigational New Drugs · doi:10.1007/s10637-008-9131-6 · Cited by 174
The Emerging Therapeutic Potential of Histone Methyltransferase and Demethylase Inhibitors
Spannhoff, A., Hauser, A., Heinke, R., Sippl, W., & Jung, M. (2009) · ChemMedChem · doi:10.1002/cmdc.200900301 · Cited by 171
Park, M. A., Zhang, G., Martin, A. P., Hamed, H., Mitchell, C., Hylemon, P. B., Graf, M., Rahmani, M., Ryan, K., Liu, X., et al. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.10.6623 · Cited by 171
Wohlhueter, R. M., McIvor, R. S., & Plagemann, P. G. W. (1980) · Journal of Cellular Physiology · doi:10.1002/jcp.1041040305 · Cited by 171
Danenberg, P. V., Langenbach, R. J., & Heidelberger, C. (1974) · Biochemistry · doi:10.1021/bi00702a016 · Cited by 171
Fas and Fas Ligand Interactions Suppress Melanoma Lung Metastasis
Owen-Schaub, L. B., van Golen, K. L., Hill, L. L., & Price, J. E. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1717 · Cited by 168
NF-κB Directly Regulates Fas Transcription to Modulate Fas-mediated Apoptosis and Tumor Suppression
Liu, F., Bardhan, K., Yang, D., Thangaraju, M., Ganapathy, V., Waller, J. L., Liles, G. B., Lee, J. R., & Liu, K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.356279 · Cited by 168
Self-citationCurcumin Modulates DNA Methylation in Colorectal Cancer Cells
Link, A., Balaguer, F., Shen, Y., Lozano, J. J., Leung, H.-C. E., Boland, C. R., & Goel, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057709 · Cited by 167
Baba, Y., Huttenhower, C., Nosho, K., Tanaka, N., Shima, K., Hazra, A., Schernhammer, E. S., Hunter, D. J., Giovannucci, E. L., Fuchs, C. S., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-125 · Cited by 160
Expression of HDAC1 and CBP/p300 in human colorectal carcinomas
Ishihama, K., Yamakawa, M., Semba, S., Takeda, H., Kawata, S., Kimura, S., & Kimura, W. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.029165 · Cited by 158
Epigenetic Drug Discovery: Targeting DNA Methyltransferases
Foulks, J. M., Parnell, K. M., Nix, R. N., Chau, S., Swierczek, K., Saunders, M., Wright, K., Hendrickson, T. F., Ho, K.-K., McCullar, M. V., et al. (2012) · SLAS Discovery · doi:10.1177/1087057111421212 · Cited by 158
DNMT3B Expression Might Contribute to CpG Island Methylator Phenotype in Colorectal Cancer
Nosho, K., Shima, K., Irahara, N., Kure, S., Baba, Y., Kirkner, G. J., Chen, L., Gokhale, S., Hazra, A., Spiegelman, D. L., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2383 · Cited by 156
DNA methylation predicts recurrence from resected stage III proximal colon cancer
Ahn, J. B., Chung, W., Maeda, O., Shin, S. J., Kim, H. S., Chung, H. C., Kim, N. K., & Issa, J. J. (2010) · Cancer · doi:10.1002/cncr.25737 · Cited by 154
Crea, F., Nobili, S., Paolicchi, E., Perrone, G., Napoli, C., Landini, I., Danesi, R., & Mini, E. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.08.001 · Cited by 153
Ibrahim, A. E. K., Arends, M. J., Silva, A.-L., Wyllie, A. H., Greger, L., Ito, Y., Vowler, S. L., Huang, T. H. ‐., Tavaré, S., Murrell, A., et al. (2010) · Gut · doi:10.1136/gut.2010.223602 · Cited by 153
Identification of genes conferring resistance to 5-fluorouracil
Yoo, B. K., Gredler, R., Vozhilla, N., Su, Z.-Z., Chen, D., Forcier, T., Shah, K., Saxena, U. H., Hansen, U. M., Fisher, P. B., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901451106 · Cited by 151
Global Histone H4 Acetylation and HDAC2 Expression in Colon Adenoma and Carcinoma
Ashktorab, H., Belgrave, K., Hosseinkhah, F., Brim, H., Nouraie, M. S., Takkikto, M., Hewitt, S. M., Lee, E. L., Dashwood, R. H., & Smoot, D. T. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0601-7 · Cited by 149
miRNA Expression in Colon Polyps Provides Evidence for a Multihit Model of Colon Cancer
Oberg, A. L., French, A. J., Sarver, A. L., Subramanian, S., Morlan, B. W., Riska, S. M., Borralho, P. M., Cunningham, J. M., Boardman, L. A., Wang, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020465 · Cited by 148
Bader, S. A., Walker, M., Hendrich, B., Bird, A. P., Bird, C. C., Hooper, M., & Wyllie, A. H. (1999) · Oncogene · doi:10.1038/sj.onc.1203229 · Cited by 147
Tai, I. T., Dai, M., Owen, D. A., & Chen, L. B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23002 · Cited by 144
Methylation and colorectal cancer
Jubb, A. M., Bell, S. M., & Quirke, P. (2001) · The Journal of Pathology · doi:10.1002/path.923 · Cited by 142
Bui, L. L., Rempel, E., Reeson, D., & Simunovic, M. R. I. (2006) · Journal of Surgical Oncology · doi:10.1002/jso.20499 · Cited by 141
The Roles of the Methyl-CpG Binding Proteins in Cancer
Parry, L., & Clarke, A. R. (2011) · Genes & Cancer · doi:10.1177/1947601911418499 · Cited by 139
Lee, S., Cho, N., Choi, M., Yoo, E. J., Kim, J. H., & Kang, G. H. (2008) · Pathology International · doi:10.1111/j.1440-1827.2007.02197.x · Cited by 136
Ha, K., Lee, G. E., Palii, S. S., Brown, K. D., Takeda, Y., Liu, K., Bhalla, K. N., & Robertson, K. D. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq451 · Cited by 134
Self-citationOgino, S., Meyerhardt, J. A., Kawasaki, T., Clark, J. W., Ryan, D. P., Kulke, M. H., Enzinger, P. C., Wolpin, B. M., Loda, M. F., & Fuchs, C. S. (2007) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-007-0398-3 · Cited by 130
Gene Expression Signature Analysis Identifies Vorinostat as a Candidate Therapy for Gastric Cancer
Claerhout, S., Lim, J. Y., Choi, W., Park, Y.-Y., Kim, K., Kim, S.-B., Lee, J., Mills, G. B., & Choi, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024662 · Cited by 124
DNMT1 and DNMT3B Modulate Distinct Polycomb-Mediated Histone Modifications in Colon Cancer
Jin, B., Yao, B., Li, J., Fields, C. R., Delmas, A. L., Liu, C., & Robertson, K. D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0116 · Cited by 123
Serrated Pathway and APC (Conventional)-Type Colorectal Polyps
Goldstein, N. S. (2005) · American Journal of Clinical Pathology · doi:10.1309/87bd0c6ucgug236j · Cited by 121
Dietary Induction of Colonic Tumors in a Mouse Model of Sporadic Colon Cancer
Yang, K., Kurihara, N., Fan, K., Newmark, H. L., Rigas, B., Bancroft, L., Corner, G. A., Livote, E. E., LESSER, M. L., Edelmann, W., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1209 · Cited by 118
EZH2 Depletion Blocks the Proliferation of Colon Cancer Cells
Fussbroich, B., Wagener, N., Macher‐Goeppinger, S., Benner, A., Fälth, M., Sültmann, H., Holzer, A., Hoppe‐Seyler, K., & Hoppe‐Seyler, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021651 · Cited by 114
Cheetham, S., Tang, M., Mesak, F., Kennecke, H. F., Owen, D., & Tai, I. T. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604377 · Cited by 111
Nosho, K., Shima, K., Irahara, N., Kure, S., Firestein, R., Baba, Y., Toyoda, S., Chen, L., Hazra, A., Giovannucci, E. L., et al. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.49 · Cited by 111
Molecular heterogeneity of colorectal cancer: Implications for cancer control
Jass, J. R. (2007) · Surgical Oncology · doi:10.1016/j.suronc.2007.10.039 · Cited by 107
Lee, J., Park, J., Jung, Y., Kim, J.-H., Jong, H.-S., Kim, T., & Bang, Y. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0419 · Cited by 103
Goel, A., Xicola, R. M., Nguyen, T., Doyle, B. J., Sohn, V. R., Bandipalliam, P., Rozek, L. S., Reyes, J., Cordero, C., Balaguer, F., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.035 · Cited by 102
Ogino, S., Odze, R. D., Kawasaki, T., Brahmandam, M., Kirkner, G. J., Laird, P. W., Loda, M. F., & Fuchs, C. S. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213266.84725.d0 · Cited by 102
Banerjee, D., Gorlick, R. G., Liefshitz, A., Danenberg, K. D., Danenberg, P., Danenberg, P. V., Klimstra, D. S., Jhanwar, S. C., Cordon‐Cardo, C., Fong, Y., et al. (2000) · PubMed · Cited by 101
Ang, P. W., Loh, M. C. S., Liem, N. L. M., Lim, P. L., Grieu, F., Vaithilingam, A., Platell, C. F. E., Yong, W. P., Iacopetta, B. J., & Soong, R. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-227 · Cited by 101
Yang, D., Thangaraju, M., Greeneltch, K. M., Browning, D. D., Schoenlein, P. V., Tamura, T., Ozato, K., Ganapathy, V., Abrams, S. I., & Liu, K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4068 · Cited by 99
Self-citationMohammad, H. P., Cai, Y., McGarvey, K. M., Easwaran, H., Neste, L. V., Ohm, J. E., O’Hagan, H. M., & Baylin, S. B. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0065 · Cited by 96
Cited by
DNA Methylation Biomarkers: Cancer and Beyond
Mikeska, T., & Craig, J. (2014) · Genes · doi:10.3390/genes5030821 · Cited by 288
Das, V., Kalita, J., & Pal, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.064 · Cited by 275
Lochhead, P., Chan, A. T., Nishihara, R., Fuchs, C. S., Beck, A. H., Giovannucci, E., & Ogino, S. (2015) · Modern Pathology · doi:10.1038/modpathol.2014.81 · Cited by 206
Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients
Li, Y.-Y., Ge, Q.-X., Cao, J., Zhou, Y.-J., Du, Y.-L., Shen, B., Wan, Y.-J. Y., & Nie, Y.-Q. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i11.3227 · Cited by 175
Porcellini, E., Laprovitera, N., Riefolo, M., Ravaioli, M., Garajova, I., & Ferracin, M. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.049 · Cited by 66
Metadata
- Authors
- Bardhan, K., & Liu, K.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2013-06-05
- Volume
- 5
- Issue
- 2
- Pages
- 676-713
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W2015611021
- Cited by
- 252
- References
- 258
- FWCI
- 9.68
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.